On May 21, 2026, Jaguar Health, Inc. completed an exchange transaction with Streeterville Capital, issuing 54,222 common shares in exchange for 7.96 shares of Series Q Preferred Stock. The company also adjourned its Annual Meeting to June 2, 2026, for further shareholder proposals review.